Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca and Oxford University announce landmark agreement for COVID-19 vaccine
-
First-quarter 2020 results
-
Lynparza demonstrated overall survival benefit in Phase III PROfound trial for BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer
-
AstraZeneca and Saint Luke’s Mid America Heart Institute initiate Phase III DARE-19 trial with Farxiga in COVID-19 patients
-
AstraZeneca initiates CALAVI clinical trial with Calquence against COVID-19
-
Koselugo (selumetinib) approved in US for paediatric patients with neurofibromatosis type 1 plexiform neurofibromas
-
Tagrisso Phase III ADAURA trial will be unblinded early after overwhelming efficacy in the adjuvant treatment of patients with EGFR-mutated lung cancer
-
AstraZeneca divestment of Movantik to RedHill Biopharma completed
-
Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis
-
Brilinta reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
Latest articles and press releases
All of our latest press releases and articles are available to explore
